Binges and Neural Variability (BEDVAR)

August 10, 2021 updated by: University Hospital Tuebingen

What is Driving the Binge in Binge Eating Disorder? Variability in Brain Response to Reward and the Escalation of Consumption

People who suffer from binge eating disorder experience recurrent episodes of binge eating.During these episodes, they consume an unusually large amount of food in a short amount of time and experience loss of control over eating. However, why such binge eating episodes occur is still largely unknown. This makes it difficult to develop targeted treatments. In this project, the experimenters are investigating the brain mechanisms that give rise to the disorder. They hypothesize that the binge eating episodes are due to an increased variability in reward processing, which they will assess repeatedly over days. They will test this hypothesis using mathematical models based on behavioural and MRI measurements that are related to the processing of rewards.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

61

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Deutschland (deu)
      • Tübingen, Deutschland (deu), Germany, 72070
        • Psychological Institute, University of Tübingen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 69 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The control group will consist of residents of the general area around Tübingen, Germany.

BED patients will be recruited mainly from the outpatient clinic of the Department of Clinical Psychology of Tübingen, Germany.

Description

Inclusion Criteria:

  • Binge eating disorder diagnosis
  • Subsyndromal binge eating (control)

Exclusion Criteria:

  • high risk of suicide
  • co-occurring psychotic, bi-polar disorders, alcohol/substance dependence within the past six months
  • lack of capacity for consent
  • medical disorders that would affect weight and ability to participate
  • insufficient German language skills (assessment will be in German)
  • taking medication that would affect weight
  • MRI exclusion criteria
  • irremovable metal attached to the body (e.g. piercings)
  • irremovable medical devices (e.g. pacemakers)
  • any trauma or surgery which may have left ferromagnetic material in the body
  • large tattoos
  • pregnancy
  • claustrophobia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Binge eating disorder (BED) patients
Individuals with BED diagnosis.
(Imaging while) performing reward related tasks.
non-BED controls
Individuals that do not experience binges
(Imaging while) performing reward related tasks.
subsyndromal BED controls
individuals that experience binges but do not fulfill the requirements for BED diagnosis.
(Imaging while) performing reward related tasks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variability in blood-oxygen-level dependent (BOLD) signalling in the NAcc during effort allocation task
Time Frame: 100 min
Variability of BOLD signal in the nucleus accumbens (NAcc) over time and between trials while performing an effort allocation task. The signal is measured through functional magnetic resonance imaging (fMRI) and variability is determined through model residuals.
100 min
Trial-to-trial variability in reward seeking in an effort allocation task
Time Frame: 40 min
Variability of performance is an intra-individual measure, that is defined by the residuals of a linear mixed effects model of trial-to-trial performance on the effort allocation task.
40 min
Variability in BOLD signalling in the NAcc for food-cue reactivity
Time Frame: 15
Variability of BOLD signal in the NAcc between blocks of food pictures. The signal is measured through fMRI and variability is determined through model residuals.
15

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variability in BOLD signalling in the NAcc during non-food-cue reactivity
Time Frame: 5
Variability of BOLD signal in the NAcc between blocks of non-food pictures. The signal is measured through fMRI and variability is determined through model residuals.
5

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nils B Kroemer, Dr, University Hospital Tuebingen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 6, 2019

Primary Completion (Actual)

May 31, 2021

Study Completion (Actual)

May 31, 2021

Study Registration Dates

First Submitted

October 29, 2019

First Submitted That Met QC Criteria

November 29, 2019

First Posted (Actual)

December 4, 2019

Study Record Updates

Last Update Posted (Actual)

August 11, 2021

Last Update Submitted That Met QC Criteria

August 10, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Binge-Eating Disorder

Clinical Trials on fMRI

3
Subscribe